MARKET

ACCD

ACCD

Accolade, Inc.
NASDAQ

Real-time Quotes | Nasdaq Last Sale

7.88
-0.58
-6.86%
Closed 16:13 06/28 EDT
OPEN
8.54
PREV CLOSE
8.46
HIGH
8.77
LOW
7.82
VOLUME
1.63M
TURNOVER
--
52 WEEK HIGH
55.47
52 WEEK LOW
4.610
MARKET CAP
561.13M
P/E (TTM)
-3.9331
1D
5D
1M
3M
1Y
5Y
Earnings Preview For Accolade
Accolade (NASDAQ:ACCD) is set to give its latest quarterly earnings report on Thursday, 2022-06-30. Here's what investors need to know before the announcement. Analysts estimate that Accolade will report an earnings per share (EPS) of $-0.66.
Benzinga · 4h ago
Accolade (ACCD) Stock Jumps 7.2%: Will It Continue to Soar?
Accolade (ACCD) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Zacks · 2d ago
TCOM, EXPI and CERS among after hour movers
Gainers: Seres Therapeutics (MCRB) +8%. Sana Biotechnology (SANA) +5%. Aziyo Biologics (AZYO) +4%. eXp World Holdings (EXPI) +4%. Aurora Innovation (AUR) +3%. Losers: Trip.com Group (TCOM) -9%. Xenon Pharmaceuticals (XENE) -8%. Accolade
Seekingalpha · 6d ago
Accolade to showcase Personalized Healthcare for health plans at AHIP 2022
Accolade, Inc. (Nasdaq: ACCD), the company that provides millions of individuals and their families with Personalized Healthcare, will be at AHIP 2022 on June 21-23 in Las Vegas, NV.
PR Newswire · 06/21 13:00
Accolade to Announce Fiscal First Quarter 2023 Financial Results
SEATTLE, June 21, 2022 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), a healthcare provider that serves over 600 employers and millions of members, today announced that it will release fiscal first quarter 2023 financial results on Thursday, June 30, 2...
GlobeNewswire · 06/21 11:00
Berenberg Bank Adjusts Accolade's Price Target to $11 From $35, Maintains Buy Rating
MT Newswires · 06/17 07:53
BCAB, ADPT and ACCD are among after hour movers
Gainers: Rent the Runway (RENT) +10%. BioAtla (BCAB) +9%. Adaptive Biotechnologies Corporation (ADPT) +5%. Accolade (ACCD) +5%. Nurix Therapeutics (NRIX) +5%. Losers: DocuSign (DOCU) -23%. Stitch Fix (SFIX) -16%. Comtech Telecommunications  (CMTL)
Seekingalpha · 06/09 22:00
Accolade Announces Participation in June Investor Conferences
SEATTLE, June 02, 2022 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced that it will participate in the following upcoming investor conferences. A webcast and replay of each event will be available at ir.accolade.com. Wednesday, June 8 at ...
GlobeNewswire · 06/02 17:02
More
No Data
Learn about the latest financial forecast of ACCD. Analyze the recent business situations of Accolade, Inc. through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 16 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

31.25%Strong Buy
25.00%Buy
43.75%Hold
0.00%Under-perform
0.00%Sell
Analyst Price Target
The average ACCD stock price target is 12.86 with a high estimate of 35.00 and a low estimate of 6.00.
High35.00
Average12.86
Low6.00
Current 8.03
EPS
Actual
Estimate
-0.70-0.43-0.160.12
Q1 2022
Q2 2022
Q3 2022
Q4 2022
Q1 2023
Institutional Holdings
Institutions: 163
Institutional Holdings: 54.07M
% Owned: 80.34%
Shares Outstanding: 71.21M
TypeInstitutionsShares
Increased
60
6.89M
New
22
375.01K
Decreased
48
4.28M
Sold Out
26
2.47M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Healthcare Facilities & Services
+0.74%
Healthcare Providers & Services
+1.44%
Key Executives
Chairman/Chief Executive Officer/Executive Director
Rajeev Singh
President
Robert Cavanaugh
Chief Financial Officer
Stephen Barnes
Chief Human Resource Officer/Executive Vice President/Director of Human Resources
Jennifer Hanson
Executive Vice President/General Counsel
Richard Eskew
Executive Vice President/General Manager
Todd Clardy
Executive Vice President/General Manager
Matt Eurey
Executive Vice President
Beverly Gibson
Executive Vice President
Phong Nguyen
Executive Vice President
Britt Provost
Executive Vice President
David Wyatt
Senior Vice President/General Manager
Mike McGee
Senior Vice President
Sarah Martino
Senior Vice President
Bill Morrison
Chief Technology Officer
Harish Naidu
Other
Michael Hilton
Other
Shantanu Nundy
Other
Carolyn Young
Lead Director/Independent Director
Peter Klein
Independent Director
Jeffrey Brodsky
Independent Director
Jeffrey Jordan
Independent Director
Cindy Kent
Independent Director
Dawn Lepore
Independent Director
Elizabeth Nabel
Independent Director
Thomas Neff
Independent Director
Patricia Wadors
No Data
No Data
About ACCD
Accolade Inc. is a provider of personalized, technology-enabled solutions that helps people to understand, navigate, and utilize the healthcare system and their workplace benefits. The Company’s customers are primarily employers that deploy Accolade in order to provide employees and their families members a single place to turn for their health, healthcare, and benefits needs. Its platform combines open, cloud-based intelligent technology with multimodal support from a team of empathetic and knowledgeable Accolade Health Assistants and clinicians, including nurses, physician medical directors, and behavioral health specialists. The Company leverages its integrated capabilities, connectivity with providers and the healthcare ecosystem, and longitudinal data to engage across the member population. Its offerings are: Accolade Total Benefits, Accolade Total Care, Accolade Total Health and Benefits, Accolade Boost, the Trusted Supplier Program, and Mental Health Integrated Care solutions.

Webull offers kinds of Accolade Inc stock information, including NASDAQ:ACCD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ACCD stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading ACCD stock methods without spending real money on the virtual paper trading platform.